Correlation Between Svenska Handelsbanken and Annexin Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Svenska Handelsbanken and Annexin Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Svenska Handelsbanken and Annexin Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Svenska Handelsbanken AB and Annexin Pharmaceuticals AB, you can compare the effects of market volatilities on Svenska Handelsbanken and Annexin Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Svenska Handelsbanken with a short position of Annexin Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Svenska Handelsbanken and Annexin Pharmaceuticals.

Diversification Opportunities for Svenska Handelsbanken and Annexin Pharmaceuticals

-0.41

Correlation Coefficient

Svenska Handelsbanken  Annexin Pharmaceuticals

Very good diversification

The 3 months correlation between Svenska and Annexin is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Svenska Handelsbanken AB and Annexin Pharmaceuticals AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Annexin Pharmaceuticals and Svenska Handelsbanken is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Svenska Handelsbanken AB are associated (or correlated) with Annexin Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Annexin Pharmaceuticals has no effect on the direction of Svenska Handelsbanken i.e., Svenska Handelsbanken and Annexin Pharmaceuticals go up and down completely randomly.

Pair Corralation between Svenska Handelsbanken and Annexin Pharmaceuticals

Assuming the 90 days trading horizon Svenska Handelsbanken AB is expected to generate 0.29 times more return on investment than Annexin Pharmaceuticals. However, Svenska Handelsbanken AB is 3.45 times less risky than Annexin Pharmaceuticals. It trades about 0.08 of its potential returns per unit of risk. Annexin Pharmaceuticals AB is currently generating about 0.0 per unit of risk. If you would invest  10,645  in Svenska Handelsbanken AB on September 1, 2024 and sell it today you would earn a total of  705.00  from holding Svenska Handelsbanken AB or generate 6.62% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Svenska Handelsbanken AB  vs.  Annexin Pharmaceuticals AB

Svenska Handelsbanken

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Svenska Handelsbanken AB are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Svenska Handelsbanken may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Annexin Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Annexin Pharmaceuticals AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Annexin Pharmaceuticals is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Svenska Handelsbanken and Annexin Pharmaceuticals

The main advantage of trading using opposite Svenska Handelsbanken and Annexin Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Svenska Handelsbanken position performs unexpectedly, Annexin Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Annexin Pharmaceuticals will offset losses from the drop in Annexin Pharmaceuticals' long position.

The idea behind Svenska Handelsbanken AB and Annexin Pharmaceuticals AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.